Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Shapiro, Joel, Dr, van Lanschot, J Jan B, Prof, Hulshof, Maarten C C M, MD, van Hagen, Pieter, MD, van Berge Henegouwen, Mark I, MD, Wijnhoven, Bas P L, MD, van Laarhoven, Hanneke W M, Prof, Nieuwenhuijzen, Grard A P, MD, Hospers, Geke A P, Prof, Bonenkamp, Johannes J, MD, Cuesta, Miguel A, Prof, Blaisse, Reinoud J B, MD, Busch, Olivier R C, Prof, ten Kate, Fiebo J W, Prof, Creemers, Geert-Jan M, MD, Punt, Cornelis J A, Prof, Plukker, John Th M, Prof, Verheul, Henk M W, Prof, Bilgen, Ernst J Spillenaar, MD, van Dekken, Herman, MD, van der Sangen, Maurice J C, MD, Rozema, Tom, MD, Biermann, Katharina, MD, Beukema, Jannet C, MD, Piet, Anna H M, MD, van Rij, Caroline M, MD, Reinders, Janny G, MD, Tilanus, Hugo W, Prof, Steyerberg, Ewout W, Prof, van der Gaast, Ate, MD
Published in The lancet oncology (01.09.2015)
Published in The lancet oncology (01.09.2015)
Get full text
Journal Article